Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20933118 | 1.00 | USP2 (0.31) | USP2LMNACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL20933286 | 0.98 | HCRTR1 (0.31) | USP2LMNACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL20934095 | 0.98 | HCRTR1 (0.31) | USP2LMNACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL20933153 | 0.96 | — | — | |
| SCHEMBL20933561 | 0.96 | — | — | |
| SCHEMBL20934222 | 0.94 | HCRTR1 (0.31) | LMNAHCRTR1 | |
| SCHEMBL20933768 | 0.93 | HCRTR1 (0.31) | HCRTR1 | |
| SCHEMBL20933537 | 0.92 | ADORA2A (0.30) | — | |
| SCHEMBL20934420 | 0.92 | HCRTR1 (0.30) | HCRTR1 | |
| SCHEMBL20933503 | 0.92 | HCRTR1 (0.30) | HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019078461-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2019-04-25 | — | — | WO | disclosed |